Is UnitedHealth Group (UNH) a Buy Now After These 2 Huge Developments?
Briefly

UnitedHealth Group, the largest U.S. health insurer, has faced significant challenges in 2025, including the assassination of its CEO, a notable earnings miss, high medical costs causing a stock drop, a CEO resignation, and a DOJ probe into Medicare fraud. Additionally, a cyberattack cost the company $2.3 billion. As a result, UNH's stock lost half its value, equating to a $300 billion decline in market capitalization. However, new developments may show signs of recovery for investor sentiment.
In December, UnitedHealthcare CEO Brian Thompson was assassinated, sparking public backlash over the company's claims denial process. UNH suffered a rare first-quarter earnings miss.
UNH's stock plummeted, losing half of its value and erasing $300 billion in market capitalization. Recent developments may signal a turning point for investor sentiment.
Read at 24/7 Wall St.
[
|
]